Status:
UNKNOWN
Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective Study
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Cardiogenic Shock
Eligibility:
All Genders
18+ years
Brief Summary
Failure of Weaning from ECMO is a serious complication, reaching an incidence between 29 and 58%. Inotrops are frequently used to help separating patient from ECMO. Levosimendan is an ino-dilatatory m...
Eligibility Criteria
Inclusion
- Age over 18
- Patient requiring the need for short-term assistance
- Patient who has agreed to use his medical data for research purposes
Exclusion
- Refusal to participate in the study
- Non-weaning attempts due to a death under assistance or a relay by a long-term assistance or heart transplant
- Non-cardiac indications of assistance (indication of pulmonary replacement)
- Subject under guardianship or curatorship
Key Trial Info
Start Date :
November 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT03346824
Start Date
November 15 2017
End Date
January 1 2019
Last Update
February 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Réanimation chirurgicale cardiovasculaire-NHC
Strasbourg, France, 67091